ReviewFrontiers in oncology2025
Recent advance in early oral lesion diagnosis: the application of artificial intelligence-assisted endoscopy.
Review in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral squamous cell carcinoma (OSCC) is a globally prevalent malignancy with high mortality. Early detection is crucial, yet traditional diagnostic methods, including biopsies and imaging techniques like CT and MRI, face limitations in identifying small or superficial lesions. Endoscopic techniques, such as White Light Imaging, Narrow Band Imaging, and Autofluorescence Imaging, enhance visualization of mucosal abnormalities, but their accuracy depends on operator expertise. Recent advancements in artificial intelligence (AI) are transforming endoscopic diagnosis by enabling automated lesion detection, segmentation, and classification through deep learning models like Mask R-CNN and U-Net. These AI-driven approaches improve diagnostic precision, reduce human error, and facilitate early intervention, particularly in resource-limited settings. Challenges persist, including the need for standardized datasets, robust preprocessing methods, and strategies to address overfitting in AI models. Techniques such as transfer learning, data augmentation, and multitask learning are employed to overcome these limitations. AI-assisted endoscopy holds promise for early detection, improved treatment outcomes, and enhanced accessibility, particularly in underserved regions. However, ethical concerns, data privacy, and the necessity for clinical validation remain critical. Future research should prioritize refining AI methodologies and integrating them into clinical workflows to optimize the early diagnosis and management of OSCC, thereby improving patient outcomes and reducing global disease burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.